Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Phase I results for the rituximab biosimilar PF-05280586

June 18, 2014

CKD-L, an HDAC6 inhibitor, may have potential for the treatment of RA

June 18, 2014

Rheumatoid arthritis candidate BI-638683 well tolerated in phase I study

June 18, 2014

Novel PIKfyve inhibitor described by Astellas scientists

June 17, 2014

Oncobiologics begins phase I trial of biosimilar ONS-3010

June 16, 2014

Revive Therapeutics submits pre-IND package to the FDA for REV-002

June 10, 2014

Protalex reports new data analysis from phase Ib study of PRTX-100 for rheumatoid arthritis

June 6, 2014

UCB Celltech initiates phase I trial in patients with psoriatic arthritis

May 30, 2014

Janssen withdraws application for intravenously administered Simponi in E.U.

May 23, 2014

Antibe Therapeutics submits CTA for ATB-346

May 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....